Abiopharma

🔍 BAQAR HASSAN (Director)

Company: Greenland Energy Co (GLND)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | shares_owned_after: 473,000.00
• Acquired 76,700 shares of Public Warrants at $5.0 per share (Derivative)
  Date: 2026-05-07 | Code: P | Expires: 2031-04-29 | Exercise: 2026-04-29 | equity_swap_involved: 0 | shares_owned_after: 101,700.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Holds 375,000 shares of Warrants at $15.0 per share (Derivative)
  Date: 2026-05-07 | Code: H | Expires: 2036-03-25 | Exercise: 2026-04-24 | shares_owned_after: 375,000.00 | Footnotes: F1

Footnotes:

• F1: Comprised of warrants, each exercisable for one share of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer at an exercise price of $15.00 per share. These warrants were issued to the Reporting Person in connection with the business combination consummated by the Issuer (formerly Pelican Holdco, Inc.), March GL Company, Greenland Exploration Limited, and Pelican Acquisition Corporation.
• F2: Comprised of public warrants (ticker: GLNDW), each exercisable for one share of Common Stock at an exercise price of $5.00 per share. These warrants were acquired in open market purchases.
• F3: The price reported is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per warrant. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote.